News and Stories

A new study published in today’s issue of PLOS Pathogens is the first to link SARS-CoV-2 specific T cells to lung function and those who suffer from long-term COVID symptoms. Long COVID currently affects hundreds of millions of Americans.

Laura Kelley | June 09, 2022

As office buildings refill with employees, and grocery stores bustle with mask-less shoppers, a question remains during the biggest lull in the COVID-19 pandemic yet: What about the children?

Debra Melani | March 17, 2022

Researchers from universities in Canada and the United States have found that patients who experienced an immediate allergic reaction of any kind to a first SARS-CoV-2 vaccine dose are unlikely to experience severe immediate allergic reactions to a second dose.

Kelsea Pieters | February 22, 2022

Omicron is hitting the nation hard, pushing delta out as it infects at a higher rate of speed than any SARS-CoV-2 variant so far. In past days, infection rates in some of Colorado’s mountain towns have topped the nation, even in areas with high vaccination rates.

Debra Melani | January 11, 2022

According to her dad, Mia McMurray hates needles. The 8-year-old dutifully gets her flu shot every year, but not without dread. So when his daughter jumped at the chance to take part in a clinical trial for the COVID-19 vaccine, Michael McMurray was surprised.

Debra Melani | November 02, 2021

With the U.S. approval of another COVID-19 shot now expanded to Moderna and Johnson & Johnson recipients, the doors have opened for tens of millions of more Americans to boost their immunity against the coronavirus.

Debra Melani | October 26, 2021

A reminder to the University of Colorado Anschutz Medical Campus community: The Sept. 1 deadline for meeting the CU Anschutz COVID-19 vaccination requirement is fast approaching. If you have not yet begun the vaccination process, please take action quickly to do so. 

Staff | August 05, 2021

As a race that pits vaccine against virus forges on, a stealthy move by one contender might have just pushed the finish line farther out.

Debra Melani | July 06, 2021

As you might imagine, this is quite a time to be a scientist who does vaccine-related research. Usually, mentioning my chosen profession as an immunologist is the fastest way to get the crickets chirping at a cocktail party, but now I cannot get out of conversations with complete strangers in less than a half an hour if they find out what I do for a living.

Guest Contributor | May 27, 2021

Scientists examining the remains of 36 bubonic plague victims from a 16th century mass grave in Germany have found the first evidence that evolutionary adaptive processes, driven by the disease, may have conferred immunity on later generations from the region.

David Kelly | May 18, 2021

Women whose pregnancies were confirmed during the pandemic now face another test: making the COVID-19 vaccine decision. With a new little being inside of them, a higher risk of severe disease while pregnant and a lag in pregnancy-related data for the vaccines, their early parenting choice offers no blanket answer.

Debra Melani | April 19, 2021

Some got misty-eyed. Many felt a moment of elation. Virtually all visitors sensed the shedding of an emotional weight – a feeling that freer, happier days lie ahead.

Chris Casey | April 13, 2021

President Joe Biden has painted a bright picture for the coming Fourth of July holiday, claiming all Americans will have access to a COVID-19 vaccine by May 1. Assuming most people accept their shots, and the vaccination rate continues at its current pace, the restrictive cloud hanging over the country could finally lift by summer.

Debra Melani | March 23, 2021

For about 1.2 million Coloradans, the world suddenly appears brighter. They represent the small percentage of the state’s 5.9 million residents who, some might say, won the lottery first. They already have at least one COVID-19 shot.

Debra Melani | March 16, 2021

At a time when life before COVID-19 seems like a dream, a vaccine rollout garnering the world’s attention offers a glimpse of hope for a return to pre-pandemic life. But, as with everything SARS-CoV-2-related, questions and uncertainties remain.

Debra Melani | February 18, 2021

Ross Kedl, PhD, doesn’t mince words when he describes the effects of his COVID-19 vaccine: “It packs a wallop,” said the University of Colorado School of Medicine professor.

Debra Melani | February 18, 2021

On Dec. 14, when the first COVID-19 vaccine hit Colorado, healthcare providers were cast into another trying mission: Vaccinate the state’s 5.7 million residents as rapidly as possible to end the pandemic. Their average weekly supply? About 60,000 doses.

Debra Melani | February 11, 2021